SCHEMBL16479476

SCHEMBL16479476

O=c1ccc(C(F)(F)F)cn1-c1ccc(OC(F)(F)F)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPV1 Q8NER1 1/20 0.43
POLB P06746 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
CBL P22681 1/20 0.39
CBLB Q13191 1/20 0.39
CHRM5 P08912 1/20 0.39
MAPT P10636 2/20 0.38
NPC1 O15118 1/20 0.38
LMNA P02545 1/20 0.38
RAB9A P51151 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
PPARD Q03181 2/20 0.37
PPARA Q07869 2/20 0.37
SCN5A Q14524 1/20 0.37
EPHX2 P34913 1/20 0.37
ATM Q13315 1/20 0.36
ALDH1A1 P00352 1/20 0.36
TP53 P04637 1/20 0.36
PTGS2 P35354 1/20 0.36
PDE10A Q9Y233 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12333052 0.84 GSK3A (0.42) TRPV1L3MBTL1CBLCBLBALDH1A1
SCHEMBL10059511 0.84 POLB (0.42) POLBL3MBTL1MAPTNPC1LMNA
SCHEMBL145883 0.84 ALDH1A1 (0.50) POLBL3MBTL1RAB9AALDH1A1TP53
SCHEMBL10059787 0.83 KDM4E (0.56) POLBL3MBTL1PPARDPPARAATM
SCHEMBL16474667 0.83 POLB (0.41) POLBL3MBTL1CHRM5MAPTNPC1
SCHEMBL1423477 0.83 TRPV1 (0.41) TRPV1POLBL3MBTL1MAPTNPC1
SCHEMBL18077692 0.81 MAPK14 (0.43) L3MBTL1CBLCBLBALDH1A1TP53
SCHEMBL10079105 0.80 NPBWR1 (0.41) POLBL3MBTL1MAPTNPC1LMNA
SCHEMBL142716 0.80 NPC1 (0.46) CBLCBLBNPC1LMNARAB9A
SCHEMBL10059811 0.79 PDE10A (0.54) CHRM5MAPTNPC1LMNARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2903991-B1 ANTI-FIBROTIC PYRIDINONES INTERMUNE INC (US) 2020-09-16 EP disclosed
US-10544161-B2 Anti-fibrotic pyridinones INTERMUNE, INC. (US) 2020-01-28 US disclosed
US-20190321343-A1 Anti-Fibrotic Pyridinones GENENTECH, INC. 2019-10-24 US disclosed
US-10376497-B2 Anti-fibrotic pyridinones INTERMUNE, INC. (US) 2019-08-13 US disclosed
US-20190144467-A1 ANTI-FIBROTIC PYRIDINONES GENENTECH, INC. 2019-05-16 US disclosed
US-10233195-B2 Anti-fibrotic pyridinones INTERMUNE, INC. (US) 2019-03-19 US disclosed
US-20180064692-A1 Anti-Fibrotic Pyridinones GENENTECH, INC. 2018-03-08 US disclosed
US-9675593-B2 Anti-fibrotic pyridinones INTERMUNE, INC. (US) 2017-06-13 US disclosed
US-20170121345-A1 ANTI-FIBROTIC PYRIDINONES GENENTECH, INC. 2017-05-04 US disclosed
US-9359379-B2 Anti-fibrotic pyridinones INTERMUNE, INC. (US) 2016-06-07 US disclosed
WO-2015153683-A1 ANTI-FIBROTIC PYRIDINONES INTERMUNE, INC. (US) 2015-10-08 WO disclosed
US-20140107110-A1 ANTI-FIBROTIC PYRIDINONES GENENTECH, INC. 2014-04-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180064692-A1 Anti-Fibrotic Pyridinones MMP1, COL1A1, COL2A1 TRPV1 4661/4885POLB 1266/4885L3MBTL1 4144/4885
US-10544161-B2 Anti-fibrotic pyridinones MMP1, COL1A1, COL2A1 TRPV1 4661/4885POLB 1266/4885L3MBTL1 4144/4885
US-20190321343-A1 Anti-Fibrotic Pyridinones MMP1, COL1A1, COL2A1 TRPV1 4661/4885POLB 1266/4885L3MBTL1 4144/4885
US-20140107110-A1 ANTI-FIBROTIC PYRIDINONES MMP1, COL1A1, COL2A1 TRPV1 4661/4885POLB 1266/4885L3MBTL1 4144/4885
US-10233195-B2 Anti-fibrotic pyridinones MMP1, COL1A1, COL2A1 TRPV1 4661/4885POLB 1266/4885L3MBTL1 4144/4885
US-10376497-B2 Anti-fibrotic pyridinones MMP1, COL1A1, COL2A1 TRPV1 4661/4885POLB 1266/4885L3MBTL1 4144/4885
US-20170121345-A1 ANTI-FIBROTIC PYRIDINONES MMP1, COL1A1, COL2A1 TRPV1 4661/4885POLB 1266/4885L3MBTL1 4144/4885
US-20190144467-A1 ANTI-FIBROTIC PYRIDINONES MMP1, COL1A1, COL2A1 TRPV1 4661/4885POLB 1266/4885L3MBTL1 4144/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.